What is Resurrect Bio?
Resurrect Bio is at the forefront of agricultural innovation, specializing in the development of disease-resistant crops. Leveraging a proprietary gene editing platform, the company focuses on resurrecting native resistance genes found in wild relatives and heritage varieties. This approach offers the seed industry a sustainable alternative to conventional chemical crop protection methods. Spun out of The Sainsbury Laboratory in Norwich, Resurrect Bio was founded by Prof. Sophien Kamoun, Prof. Tolga Bozkurt, and Dr. Cian Duggan, bringing together deep scientific expertise to address critical challenges in global food security and sustainable agriculture.
How much funding has Resurrect Bio raised?
Resurrect Bio has raised a total of $20.4M across 3 funding rounds:
Unspecified
$2M
Series A
$8.1M
Series A
$10.3M
Unspecified (2023): $2M with participation from SHAKE Climate Change, UKI2S, SynBioVen, and AgFunder
Series A (2026): $8.1M led by AgFunder, SynBioVen, Pymwymic, Calculus Capital, Corteva Agriscience, and Uki2s
Series A (2026): $10.3M supported by Uki2s, Future Planet Capital, Corteva Agriscience, SynBioVen, Pymwymic, AgFunder, and Calculus Capital
Key Investors in Resurrect Bio
Uki2s
UKI2S is a prominent UK-based fund focused on early-stage businesses tackling global challenges, particularly in sectors like engineering biology. They provide not only capital but also mentorship and strategic support to their portfolio companies.
Future Planet Capital
Future Planet Capital is a UK venture capital firm with an impact-led approach, investing in companies addressing global challenges aligned with UN Sustainable Development Goals, including those in climate change and health.
Corteva Agriscience
Corteva Agriscience is a major player in the agriculture business, offering advanced germplasm, trait technologies for crop resistance, and digital solutions for farmers, alongside crop protection products.
What's next for Resurrect Bio?
With its recent substantial financing, Resurrect Bio is poised for accelerated growth and market penetration. The strategic investment will likely fuel further research and development, expand its gene editing capabilities, and support the commercialization of its disease-resistant crop varieties. The company's focus on sustainable agriculture and its strong scientific foundation position it well to capture a significant share of the evolving agritech market. Future expansion may involve strategic partnerships with larger agricultural corporations and broader adoption of its technology across diverse crop types and geographies, reinforcing its role in building a more resilient and environmentally conscious food system.
See full Resurrect Bio company page
